⟵ Go Back

Monarch Bioimplants Awarded European Patent

January 2019

The patent that covers the intellectual property of Monarch Bioimplants GmbH has been granted in Europe.

Monarch Bioimplants has been granted an European patent (# EP3266467B1) to protect its advanced chitosan-based technology for use in the prevention and/or treatment of incontinence and impotence in patients undergoing radical prostatectomy. 

The company is continuing to expand its patent portfolio.